Covid-associated pulmonary mucormycosis.
作者信息
Kumar Arvind, Pulle Mohan V, Asaf Belal B, Puri Harsh V
机构信息
Institute of Chest Surgery, Chest Onco Surgery and Lung Transplantation, Medanta The Medicity, Gurugram, Haryana, India.
出版信息
Lung India. 2022 Mar-Apr;39(2):100-101. doi: 10.4103/lungindia.lungindia_95_22.
Abstract
摘要
相似文献
1
Covid-associated pulmonary mucormycosis.新型冠状病毒肺炎相关肺毛霉菌病
Lung India. 2022 Mar-Apr;39(2):100-101. doi: 10.4103/lungindia.lungindia_95_22.
2
Massive hemoptysis causing mortality in a post COVID-19 infected Asian male patient: Presenting as pulmonary mucormycosis, pulmonary tuberculosis and later sino-nasal mucormycosis.一名感染新冠病毒后的亚洲男性患者因大量咯血死亡：表现为肺毛霉菌病、肺结核，随后发展为鼻-鼻窦毛霉菌病。
Respir Med Case Rep. 2021;34:101511. doi: 10.1016/j.rmcr.2021.101511. Epub 2021 Sep 4.
3
COVID-19 associated pulmonary mucormycosis: A systematic review of published cases with review of literature.新型冠状病毒肺炎相关肺毛霉病：已发表病例的系统评价及文献综述
J Family Med Prim Care. 2022 Apr;11(4):1244-1249. doi: 10.4103/jfmpc.jfmpc_1307_21. Epub 2022 Mar 18.
4
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.重症新型冠状病毒肺炎相关肺毛霉病：毛霉病疫情中未得到充分报道的危及生命的情况。
Lung India. 2022 Mar-Apr;39(2):187-190. doi: 10.4103/lungindia.lungindia_435_21.
5
Two Uncommon Presentations of COVID-19-Associated Mucormycosis.新型冠状病毒肺炎相关毛霉菌病的两种罕见表现
Cureus. 2022 Jan 14;14(1):e21229. doi: 10.7759/cureus.21229. eCollection 2022 Jan.
6
Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.COVID-19 相关肺毛霉菌病中的肺动脉假性动脉瘤：病例系列和文献系统评价。
Mycopathologia. 2022 Feb;187(1):31-37. doi: 10.1007/s11046-021-00610-9. Epub 2021 Dec 22.
7
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.冠状病毒病（新冠-19）相关毛霉菌病（CAM）：病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
8
COVID-19-associated mucormycosis: Preliminary report from a tertiary eye care centre.COVID-19 相关毛霉病：来自一家三级眼科护理中心的初步报告。
Indian J Ophthalmol. 2021 Dec;69(12):3685-3689. doi: 10.4103/ijo.IJO_2085_21.
9
Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.COVID 相关毛霉病在肾移植受者中的危险因素和结局。
Transpl Infect Dis. 2022 Apr;24(2):e13777. doi: 10.1111/tid.13777. Epub 2022 Jan 31.
10
Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes.新型冠状病毒肺炎相关毛霉菌病的口腔表现：诊断、管理策略与结果
J Fungi (Basel). 2021 Dec 31;8(1):44. doi: 10.3390/jof8010044.
引用本文的文献
1
Neuro-mucormycosis: Lessons from COVID-19-associated cases.神经毛霉菌病：COVID-19相关病例的经验教训
Curr J Neurol. 2023 Oct 7;22(4):255-260. doi: 10.18502/cjn.v22i4.14531.
本文引用的文献
1
Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic.重症新型冠状病毒肺炎相关肺毛霉病：毛霉病疫情中未得到充分报道的危及生命的情况。
Lung India. 2022 Mar-Apr;39(2):187-190. doi: 10.4103/lungindia.lungindia_435_21.
2
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.COVID-19 相关毛霉病的出现：来自 18 个国家的病例回顾。
Lancet Microbe. 2022 Jul;3(7):e543-e552. doi: 10.1016/S2666-5247(21)00237-8. Epub 2022 Jan 25.
3
Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis.肺毛霉菌病早期抗真菌治疗联合积极手术切除的疗效
Lung India. 2021 Jul-Aug;38(4):314-320. doi: 10.4103/lungindia.lungindia_758_20.
4
Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.印度冠状病毒疾病相关毛霉菌病的多中心流行病学研究。
Emerg Infect Dis. 2021 Sep;27(9):2349-2359. doi: 10.3201/eid2709.210934. Epub 2021 Jun 4.
5
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.当未控制的糖尿病与重症 COVID-19 相遇：毛霉菌病的完美风暴。
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
6
SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis.严重急性呼吸综合征冠状病毒2型、未控制的糖尿病与皮质类固醇——颌面区域侵袭性真菌感染中的“邪恶三位一体”？一项回顾性多中心分析
J Maxillofac Oral Surg. 2021 Sep;20(3):418-425. doi: 10.1007/s12663-021-01532-1. Epub 2021 Mar 6.
7
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.冠状病毒病（新冠-19）相关毛霉菌病（CAM）：病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
8
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.SARS-CoV-2 感染后的一个具有挑战性的并发症：一例肺毛霉菌病。
Infection. 2021 Oct;49(5):1055-1060. doi: 10.1007/s15010-020-01561-x. Epub 2020 Dec 17.
9
Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks.在两周内将一家综合医院改造成用于治疗 COVID-19 的传染病医院。
Front Public Health. 2020 Jul 28;8:382. doi: 10.3389/fpubh.2020.00382. eCollection 2020.
10
COVID-19 infection may cause ketosis and ketoacidosis.COVID-19 感染可能导致酮症和酮酸中毒。
Diabetes Obes Metab. 2020 Oct;22(10):1935-1941. doi: 10.1111/dom.14057. Epub 2020 May 18.
Zotero 插件